Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 10mg;   - capsule - 10 mg - active: oxycodone hydrochloride 10mg   excipient: gelatin indigo carmine iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose sodium laurilsulfate titanium dioxide - the management of opioid responsive, moderate to severe pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 20mg;   - capsule - 20 mg - active: oxycodone hydrochloride 20mg   excipient: gelatin indigo carmine iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose sodium laurilsulfate titanium dioxide - the management of opioid responsive, moderate to severe pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 5mg;   - capsule - 5 mg - active: oxycodone hydrochloride 5mg   excipient: gelatin indigo carmine iron oxide red iron oxide yellow magnesium stearate microcrystalline cellulose sodium laurilsulfate sunset yellow fcf titanium dioxide - the management of opioid responsive, moderate to severe pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 1 mg/ml - oral solution - 5 mg/5ml - active: oxycodone hydrochloride 1 mg/ml excipient: citric acid monohydrate hydrochloric acid hypromellose purified water saccharin sodium sodium benzoate sodium citrate dihydrate sodium hydroxide - the management of opioid responsive, moderate to severe pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 10 mg/ml - solution for injection - 10 mg/ml - active: oxycodone hydrochloride 10 mg/ml excipient: citric acid monohydrate hydrochloric acid purified water sodium chloride sodium citrate dihydrate sodium hydroxide - the management of opioid-responsive moderate to severe pain

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 50 mg/ml equivalent to oxycodone base 45 mg - solution for injection - 50 mg/ml - active: oxycodone hydrochloride 50 mg/ml equivalent to oxycodone base 45 mg excipient: citric acid monohydrate hydrochloric acid nitrogen sodium chloride sodium citrate sodium hydroxide water for injection - the management of opioid-responsive moderate to severe pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 5.45mg equivalent to naloxone hydrochloride anhydrous 5 mg; oxycodone hydrochloride 10mg;   - modified release tablet - 10/5mg - active: naloxone hydrochloride dihydrate 5.45mg equivalent to naloxone hydrochloride anhydrous 5 mg oxycodone hydrochloride 10mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry white 85f18422 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 10.9mg equivalent to naloxone hydrochloride anhydrous 10 mg; oxycodone hydrochloride 20mg;   - modified release tablet - 20/10mg - active: naloxone hydrochloride dihydrate 10.9mg equivalent to naloxone hydrochloride anhydrous 10 mg oxycodone hydrochloride 20mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry pink 85f24151 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 21.8mg equivalent to naloxone hydrochloride anhydrous 20 mg; oxycodone hydrochloride 40mg;   - modified release tablet - 40/20mg - active: naloxone hydrochloride dihydrate 21.8mg equivalent to naloxone hydrochloride anhydrous 20 mg oxycodone hydrochloride 40mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry yellow 85f32109 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 2.73mg equivalent to naloxone hydrochloride anhydrous 2.5 mg; oxycodone hydrochloride 5mg;   - modified release tablet - 5/2.5mg - active: naloxone hydrochloride dihydrate 2.73mg equivalent to naloxone hydrochloride anhydrous 2.5 mg oxycodone hydrochloride 5mg   excipient: ethylcellulose hyprolose lactose monohydrate magnesium stearate opadry blue 85f30569 purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.